Trial record 1 of 1 for:    OPT-80-302
Previous Study | Return to List | Next Study

Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (DEFLECT-1)

This study is currently recruiting participants.
Verified November 2013 by Optimer Pharmaceuticals
Information provided by (Responsible Party):
Optimer Pharmaceuticals Identifier:
First received: September 19, 2012
Last updated: November 1, 2013
Last verified: November 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2014
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)